Skip to main content
eScholarship
Open Access Publications from the University of California

Exercise intolerance in heart failure with preserved ejection fraction: Diagnosing and ranking Its causes using personalized O2pathway analysis

  • Author(s): Houstis, NE
  • Eisman, AS
  • Pappagianopoulos, PP
  • Wooster, L
  • Bailey, CS
  • Wagner, PD
  • Lewis, GD
  • et al.
Abstract

© 2018 American Heart Association, Inc. Background: Heart failure with preserved ejection fraction (HFpEF) is a common syndrome with a pressing shortage of therapies. Exercise intolerance is a cardinal symptom of HFpEF, yet its pathophysiology remains uncertain. Methods: We investigated the mechanism of exercise intolerance in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 controls. We performed cardiopulmonary exercise testing with invasive monitoring to measure hemodynamics, blood gases, and gas exchange during exercise. We used these measurements to quantify 6 steps of oxygen transport and utilization (the O2pathway) in each patient with HFpEF, identifying the defective steps that impair each one's exercise capacity (peak Vo2). We then quantified the functional significance of each O2pathway defect by calculating the improvement in exercise capacity a patient could expect from correcting the defect. Results: Peak Vo2was reduced by 34±2% (mean±SEM, P<0.001) in HFpEF compared with controls of similar age, sex, and body mass index. The vast majority (97%) of patients with HFpEF harbored defects at multiple steps of the O2pathway, the identity and magnitude of which varied widely. Two of these steps, cardiac output and skeletal muscle O2diffusion, were impaired relative to controls by an average of 27±3% and 36±2%, respectively (P<0.001 for both). Due to interactions between a given patient's defects, the predicted benefit of correcting any single one was often minor; on average, correcting a patient's cardiac output led to a 7±0.5% predicted improvement in exercise intolerance, whereas correcting a patient's muscle diffusion capacity led to a 27±1% improvement. At the individual level, the impact of any given O2pathway defect on a patient's exercise capacity was strongly influenced by comorbid defects. Conclusions: Systematic analysis of the O2pathway in HFpEF showed that exercise capacity was undermined by multiple defects, including reductions in cardiac output and skeletal muscle diffusion capacity. An important source of disease heterogeneity stemmed from variation in each patient's personal profile of defects. Personalized O2pathway analysis could identify patients most likely to benefit from treating a specific defect; however, the system properties of O2transport favor treating multiple defects at once, as with exercise training.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View